• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Reliable and accurate diagnostics from highly multiplexed sequencing assays

tetano

Editor, Senior Moderator
Sci Rep


. 2020 Dec 10;10(1):21759.
doi: 10.1038/s41598-020-78942-7.
Reliable and accurate diagnostics from highly multiplexed sequencing assays


A Sina Booeshaghi[SUP] 1 [/SUP], Nathan B Lubock[SUP] 2 [/SUP], Aaron R Cooper[SUP] 2 [/SUP], Scott W Simpkins[SUP] 2 [/SUP], Joshua S Bloom[SUP] 2 3 [/SUP], Jase Gehring[SUP] 4 [/SUP], Laura Luebbert[SUP] 5 [/SUP], Sri Kosuri[SUP] 2 [/SUP], Lior Pachter[SUP] 6 7 [/SUP]



Affiliations

Abstract

Scalable, inexpensive, and secure testing for SARS-CoV-2 infection is crucial for control of the novel coronavirus pandemic. Recently developed highly multiplexed sequencing assays (HMSAs) that rely on high-throughput sequencing can, in principle, meet these demands, and present promising alternatives to currently used RT-qPCR-based tests. However, reliable analysis, interpretation, and clinical use of HMSAs requires overcoming several computational, statistical and engineering challenges. Using recently acquired experimental data, we present and validate a computational workflow based on kallisto and bustools, that utilizes robust statistical methods and fast, memory efficient algorithms, to quickly, accurately and reliably process high-throughput sequencing data. We show that our workflow is effective at processing data from all recently proposed SARS-CoV-2 sequencing based diagnostic tests, and is generally applicable to any diagnostic HMSA.
 
Back
Top Bottom